Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Fusion Pharmaceuticals Inc.

Clinical trials sponsored by Fusion Pharmaceuticals Inc., explained in plain language.

Now part of AstraZeneca PLC AZN NASDAQ

A clinical-stage biotech developing targeted alpha-particle therapies for cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 3 Terminated 1

Radioactive 'Smart Bomb' for tumours tested in early trial

Disease control Terminated

This early-phase trial tested a radioactive drug designed to seek out and destroy cancer cells in people with advanced solid tumours that had stopped responding to other treatments. The drug targets a protein called IGF-1R found on many cancer cells. The study aimed to find a saf…

Phase: PHASE1 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:08 UTC